gvtcx

NHS Framework agreement for Branded Medicines - North of England - Tranche A

NHS England Published 24 Oct 2018 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£204,551,038
Statuscomplete
Category (CPV) 33600000
RegionNorth East, North West, Yorkshire and the Humber
Deadline26 Nov 2018
Contract start1 Mar 2019
Contract end28 Feb 2021
Procedureopen
SME suitableYes
OCIDocds-b5fd17-2e43909f-31cc-4421-9f28-e9e4f18738ed

Awards (25)

This procurement was awarded to 25 suppliers. Values shown are per-award; the notice total is £204,551,038.

SupplierValueDateStatus
ABBVIE LTD shared £204,551,038 18 Feb 2019 active
ACCORD LIMITED shared £204,551,038 18 Feb 2019 active
ALLERGAN LIMITED shared £204,551,038 18 Feb 2019 active
AMGEN LIMITED shared £204,551,038 18 Feb 2019 active
BMS LIMITED shared £204,551,038 18 Feb 2019 active
CHUGAI PHARMA U.K. LTD. shared £204,551,038 18 Feb 2019 active
ELI LILLY AND COMPANY LIMITED shared £204,551,038 18 Feb 2019 active
FERRING LTD shared £204,551,038 18 Feb 2019 active
GILEAD LTD shared £204,551,038 18 Feb 2019 active
IPSEN LIMITED shared £204,551,038 18 Feb 2019 active
JANSSEN LIMITED shared £204,551,038 18 Feb 2019 active
MERCK SERONO LIMITED shared £204,551,038 18 Feb 2019 active
MERZ PHARMA UK LIMITED shared £204,551,038 18 Feb 2019 active
MSD LIMITED shared £204,551,038 18 Feb 2019 active
NAPP PHARMACEUTICAL GROUP LIMITED shared £204,551,038 18 Feb 2019 active
NOVARTIS PHARMACEUTICALS UK LIMITED shared £204,551,038 18 Feb 2019 active
NOVO NORDISK LIMITED shared £204,551,038 18 Feb 2019 active
PFIZER LIMITED shared £204,551,038 18 Feb 2019 active
PHARMACOSMOS UK LIMITED shared £204,551,038 18 Feb 2019 active
ROCHE PHARMACEUTICALS LIMITED shared £204,551,038 18 Feb 2019 active
SANDOZ LIMITED shared £204,551,038 18 Feb 2019 active
TAKEDA UK LIMITED shared £204,551,038 18 Feb 2019 active
TEVA PHARMACEUTICALS LIMITED shared £204,551,038 18 Feb 2019 active
VIFOR PHARMA UK LIMITED shared £204,551,038 18 Feb 2019 active
VIIV HEALTHCARE LIMITED shared £204,551,038 18 Feb 2019 active

description

NHS Framework for North of England, Branded Medicines - Tranche A

CM/PHR/16/5526/01- 1 March 2019 to 28 February 2021 (Option to extend for up to 24 months)

CM/PHR/16/5526/02- 1 March 2019 - 29 February 2020 (option to extend for up to 12 months)

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
3 May 2019 Award (award) · 50f11a5a-678d-420e-9d66-52403a32e9df-287605

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.